Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.
Non-Profit Trusted Source of Non-Commercial Health Information
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients. Bamlanivimab is authorized for patients with positive results of direct SARS-CoV-2 viral testing who are 12 years of age and older weighing at least 40 …
Just days after putting a halt on the expanded emergency use of plasma to treat COVID-19 patients due to efficacy concerns and the data behind it cited by Dr. Fauci, Dr. Lane and Dr. Collins, prompting a stronger review of the available data, the FDA has now given the emergency use approval for the expanded …
The FDA was in the process to allow the emergency use of blood plasma donation from those who have recovered from COVID-19. However, this authorization has been put hold as they are reviewing more data. Officials say that the emergency approval could still be issued in the future, but not at this time, as quoted …
The US FDA has granted an emergency use authorization to Becton Dickson and CO for a rapid COVID-19 antigen test that can be administered at the point of care to produce results within 15 minutes; and in early trading shares for the company have increased $5.40 which is about 2.3%. Antigen testing works by scanning …
The FDA has revoked the EUA granted to the antimalarial drugs chloroquine phosphate and the less toxic metabolite hydroxychloroquine sulfate for treatments against COVID-19, this repeal cites a lack of consistent replication of earlier results and a randomized clinical trial that showed no benefit. The drugs have become a popular topic of discussion after being …